PD-1/PD-L1-IN-10
PD-1/PD-L1-IN-10 (compound B2) is an orally active PD-1/PD-L1 inhibitor (IC50 of 2.7 nM) with potent anticancer efficacy[1].
Product Specifications
CAS Number
[2487550-41-2]
UNSPSC
12352005
Target
Apoptosis; PD-1/PD-L1
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pd-1-pd-l1-in-10.html
Purity
99.61
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=C(C=CC=C1C2=CC=CC=C2)COC3=C(C=C(C(OCC4=CC(C#N)=CC=C4)=C3)CN[C@H](C(O)=O)C(O)C)[N+]([O-])=O
Molecular Formula
C33H31N3O7
Molecular Weight
581.62
References & Citations
[1]Yiqiang OuYang, et al. Design, Synthesis, and Evaluation of o- (Biphenyl-3-ylmethoxy) nitrophenyl Derivatives as PD-1/PD-L1 Inhibitors with Potent Anticancer Efficacy In Vivo. J Med Chem. 2021 May 26.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
3486M-6-250 250 µg
Anti-human/monkey Granzyme B mAb (MT8213), biotin
Sign In for Pricing
View Details 
CTLA4-2233HAF488 20 μg- 50 μg- 100 μg
Recombinant Human CTLA4 Protein, Fc/His-tagged, Alexa Fluor 488 conjugated
Sign In for Pricing
View Details 
K3919108 1.0 µg DNA
Kcnj12 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details